Daptomycin
NDC 72201-1009, Daptomycin, injection, powder, lyophilized, for solution, from Aspiro Pharma Limited.
- Product NDC
- 72201-1009
- Status
- Listed
- Labeler
- Aspiro Pharma Limited
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216413
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72201-1009 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DAPTOMYCIN500 mg/10mL
Pharmacologic classes
Lipopeptide Antibacterial [EPC]; Lipopeptides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72201-1009-0 | 72201100900 | 1 VIAL, SINGLE-DOSE in 1 CARTON (72201-1009-0) / 10 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e6fef9de-e357-4fa3-8839-f483edf1b4d0
Use it
Look up 72201-1009 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72201-1009 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72201-1009. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.